.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Maximilian Linxweiler

Vortrag

Fr, 10. Mai 2024
14:30 – 14:40 7 Min. 3 Min.
Freier Vortrag
Prevalence of actionable molecular alterations in salivary gland cancer – A clinical study on targeted therapy options for a highly malignant cancer entity
Experimentelle Onkologie, Kopf-Hals-Onkologie

Weitere Beteiligungen

Do, 09. Mai 2024
ePoster
Osteosarcoma of the left maxillary sinus – Case report of an exceedingly rare tumor entity of the paranasal sinuses
Bildgebende Verfahren, Vordere Schädelbasis / NNH / Mittelgesicht
Fr, 10. Mai 2024
10:20 – 10:30 7 Min. 3 Min.
Freier Vortrag
Use of Artificial Intelligence in automated analysis of liquid-based oral brush cytology – Development of a screening tool for head and neck cancers based on Deep Learning algorithms
Digitalisierung / Künstliche Intelligenz / eHealth / Telemedizin / Applikationen, Sonstiges
Fr, 10. Mai 2024
14:30 – 14:40 7 Min. 3 Min.
Freier Vortrag
Prevalence of actionable molecular alterations in salivary gland cancer – A clinical study on targeted therapy options for a highly malignant cancer entity
Experimentelle Onkologie, Kopf-Hals-Onkologie
Sa, 11. Mai 2024
09:45 – 09:55 7 Min. 3 Min.
Freier Vortrag
First description and surgical treatment of a primary frontobasal Ganglioneuroma
Rhinologie, Schädelbasis
Sa, 11. Mai 2024
12:15 – 12:20 3 Min. 2 Min.
Visual Abstract
Expression of the SEC62 gene represents a significant, independent prognostic parameter for patients with squamous cell carcinoma of the head and neck undergoing primary radiochemotherapy
Experimentelle Onkologie, Kopf-Hals-Onkologie
Sa, 11. Mai 2024
15:05 – 15:10 3 Min. 2 Min.
Visual Abstract
Automated detection of morphology changes in ABR waves in normal hearing using an intelligent algorithm
Audiologie / Pädaudiologie, Otologie / Neurootologie / Audiologie